Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

NEW YORK & SAN DIEGO–(BUSINESS WIRE)– #biotechnews–Revelation Biosciences to Become Publicly Traded through a Merger with Petra Acquisition, Inc.
Click here to view original post